bioXXmed AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.012233 million compared to EUR 0.044626 million a year ago. Net loss was EUR 0.829837 million compared to EUR 4.06 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.54 EUR | +1.89% | -6.90% | +21.08% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+21.08% | 3.01M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022